Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
100.00%
Operating Margin
6,335.4%
Net Margin
-7,013.8%

Efficiency Metrics

Revenue per Expense Ratio
-0.02
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
-76,638.5%
Income Tax Rate
0.00%
EPS
0.3100000000

Balance Sheet Analysis

Current Ratio
1.34
Cash Ratio
0.53
Working Capital
$24.85M
Debt to Equity
5.35
Debt to Assets
77.14%
Equity Ratio
14.41%

Cash Flow Analysis

Operating Cash Flow Ratio
15,418.5%
Free Cash Flow Ratio
15,418.5%
CapEx to Revenue
0.00%
Dividends Paid
$14.12M
Stock Buybacks
No buybacks
Total Shareholder Returns
$14.12M
Cash Position Change
10.68%

Key Takeaways (2023 FY)

  • Revenue declined by 100.32200535024%, indicating potential market challenges
  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
-100.32%
Net Income
115.10%
EPS
113.54%
Operating Income
73.22%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
41.27%
Operating Cash Flow
-144.71%
Free Cash Flow
-144.71%

Balance Sheet Health

Assets
-10.24%
Debt
-13.40%
Book Value per Share
7.25%
Inventory
0.00%

Shareholder Returns

Dividends per Share
-10.34%
Shares Outstanding
13.01%

Long Term Trends

3Y Revenue/Share
-100.21%
5Y Revenue/Share
99.03%
3Y Dividend/Share
-15.27%
5Y Dividend/Share
-36.27%